ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Acupuncture Can Relieve Side Effects of Hormone Treatment

April 29, 2011

Michael Grever To Head DTP; Chabner’s Deputy Is Kaufman; Radiation Program To Be Split

April 5, 1991

NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers

September 16, 2011

Foundation Gives Duke $2M For Brain Tumor Research.

March 23, 2001

Senate Approves 15% Increase For NIH; House Passes 5.6% Raise, But Favors More.

July 7, 2000

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011